Mapping genes that regulate density of dopamine transporters and correlated behaviors in recombinant inbred mice.
Binding of 3beta-(4-iodophenyl) tropane-2beta-carboxylic acid methyl ester ([125I]RTI-55) to the dopamine transporter (DAT) in neostriatum from C57BL/6J, DBA/2J, and 21 BXD recombinant inbred (RI) mouse strains indicated highly significant strain differences in DAT density (Bmax) but no significant differences in affinity (Kd) for this radioligand. Strain mean Bmax values and the known genomic locations of 1390 marker loci were used to carry out a genome-wide search for quantitative trait loci (QTLs), which are chromosomal sites containing genes that influence DAT expression. This search revealed an unusually large effect QTL on chromosome 19 in the region of the proopiomelanocortin pseudogene Pomc-ps1 (8-11 cM), homologous to regions of human chromosomes 9q21 and 11q12-13. This QTL (logarithm of the odds 4.7, df = 1, p = 3 x 10(-6)) by conservative estimates accounts for just over half of the genetic variation in DAT binding site density. The QTL is not the DAT gene itself (Dat1, chromosome 13), but a powerful modulator of DAT expression in neostriatum. Furthermore, DAT expression levels in 20 of the BXD RI strains and the chromosome 19 QTL were correlated with cocaine and methamphetamine-induced locomotor activation and thermic responses (hypo- or hyperthermia), but were not correlated with behaviors related to sensitization, reward, voluntary consumption, stereotypy, or seizures induced by these two psychostimulant drugs. The results suggest that there is a gene(s) on proximal chromosome 19 that strongly influences DAT expression in neostriatum and may influence psychostimulant-induced activity and thermal responses.
Janowsky
A
A
Research Service, Veterans Affairs Medical Center, Portland, Oregon 97201, USA. janowsky@ohsu.edu
Mah
C
C
Johnson
R A
RA
Cunningham
C L
CL
Phillips
T J
TJ
Crabbe
J C
JC
Eshleman
A J
AJ
Belknap
J K
JK
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001831:Body Temperature / Q000187:drug effects; D001923:Brain Chemistry / Q000235:genetics; D002352:Carrier Proteins / Q000235:genetics*; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D002874:Chromosome Mapping; D003042:Cocaine / Q000031:analogs & derivatives / Q000378:metabolism; D004274:DNA, Recombinant / Q000235:genetics; D016208:Databases, Factual; D050483:Dopamine Plasma Membrane Transport Proteins; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D051379:Mice; D008815:Mice, Inbred Strains; D009043:Motor Activity / Q000187:drug effects; D017072:Neostriatum / Q000378:metabolism; D009419:Nerve Tissue Proteins; D011869:Radioligand Assay
D002352:Carrier Proteins; D000697:Central Nervous System Stimulants; D004274:DNA, Recombinant; D050483:Dopamine Plasma Membrane Transport Proteins; D018765:Dopamine Uptake Inhibitors; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; C493215:Slc6a3 protein, mouse; C069723:2beta-carbomethoxy-3beta-(4-iodophenyl)tropane; D000661:Amphetamine; D003042:Cocaine